| 6525 |
Centers for Disease Control and Prevention |
Html |
en |
Severe Influenza Among Children and Young Adults with Neurologic and Neurodevelopmental Conditions - Ohio, 2011 |
Persons using assistive technology might not be able to fully access information in this file. For assistance, please send e-mail to: mmwrq@cdc.gov. |
| chest radiography | 0.364006 |
| Birth Defects | 0.338669 |
| Influenza Div | 0.50602 |
| influenza antiviral drugs | 0.60445 |
| severe influenza | 0.597107 |
| aggressive antiviral treatment | 0.49072 |
| neurologic impairment | 0.37706 |
| influenza antiviral medications | 0.700141 |
| residential facility | 0.424384 |
| severe neurologic | 0.348406 |
| influenza A virus | 0.515711 |
| empiric antiviral treatment | 0.465494 |
| influenza vaccine | 0.694968 |
| vaccine storage | 0.379359 |
| severely ill residents | 0.44199 |
| influenza vaccine effectiveness | 0.611711 |
| young adults | 0.477531 |
| influenza prevention | 0.550183 |
| residents | 0.544447 |
| influenza outbreak | 0.573282 |
| illness onset | 0.439539 |
| severe influenza illnesses | 0.57225 |
| baseline medical status | 0.403129 |
| influenza | 0.950859 |
| neurodevelopmental conditions | 0.843409 |
|
| influenza diagnostic test | 0.580368 |
| respiratory illness | 0.42825 |
| empiric treatment | 0.341348 |
| influenza outbreaks | 0.4834 |
| possible influenza | 0.479051 |
| health-care personnel | 0.382243 |
| infection control precautions | 0.375807 |
| confirmed influenza | 0.56753 |
| Influenza prevention efforts | 0.531764 |
| seasonal influenza vaccine | 0.599068 |
| influenza case | 0.543155 |
| laboratory-confirmed influenza | 0.533173 |
| influenza season | 0.711366 |
| long-term care facilities | 0.44248 |
| severe influenza-related illness | 0.355558 |
| staff members | 0.351426 |
| influenza vaccination | 0.492412 |
| neurologic | 0.402891 |
| antiviral chemoprophylaxis | 0.420638 |
| antiviral treatment | 0.628763 |
| early respiratory illness | 0.373484 |
| influenza viruses | 0.493007 |
| influenza antiviral treatment | 0.616542 |
| Prompt testing | 0.35967 |
|
CLICK HERE |
| 9089 |
Centers for Disease Control and Prevention |
Html |
en |
Update: Recommendations for Middle East Respiratory SyndromeCoronavirus MERS-CoV |
Persons using assistive technology might not be able to fully access information in this file. For assistance, please send e-mail to: mmwrq@cdc.gov. |
| mmwrq@cdc.gov. | 0.447567 |
| control recommendations | 0.430855 |
| case investigation | 0.430037 |
| Hospital outbreak | 0.427614 |
| Human Services | 0.536896 |
| assistive technology | 0.448302 |
| Engl J Med | 0.440209 |
| U.S. Department | 0.534078 |
| MMWR HTML versions | 0.524261 |
| CDC Emergency Operations | 0.599968 |
| electronic PDF version | 0.514433 |
| interim infection prevention | 0.597204 |
| Recent published reports | 0.55025 |
| East respiratory syndrome | 0.921509 |
| human-to-human transmission | 0.425252 |
| Additional information | 0.433606 |
| Contact GPO | 0.442109 |
| preparedness resources | 0.435824 |
| routine operations | 0.430609 |
| health-care organizations | 0.510004 |
| MERS-CoV patients | 0.466225 |
| original paper copy | 0.519099 |
| rapid detection | 0.427729 |
| specimen collection | 0.428087 |
|
| United States | 0.43684 |
| U.S. Government Printing | 0.534191 |
| original MMWR paper | 0.520894 |
| infection control | 0.467869 |
| infection prevention measures | 0.585245 |
| U.S. hospitals | 0.443212 |
| Front-line providers | 0.439681 |
| health-care personnel | 0.634523 |
| MMWR readers | 0.427742 |
| Middle East | 0.685875 |
| infectious patients | 0.442756 |
| local health departments | 0.531833 |
| MERS-CoV cases | 0.467353 |
| international settings | 0.43009 |
| CDC MERS | 0.517693 |
| subject line | 0.446556 |
| paper copy | 0.527903 |
| MERS-CoV infection | 0.490478 |
| Perl TM | 0.427535 |
| U.S. health-care | 0.523768 |
| key actions | 0.425651 |
| respiratory syndrome coronavirus | 0.980011 |
| limited health-care transmission | 0.630969 |
| current information | 0.436971 |
|
CLICK HERE |
| 10213 |
Centers for Disease Control and Prevention |
Html |
en |
Additional Information | Lightning |
CDC provides information about lightning strikes including safety tips for people indoors and outdoors, first aid recommendations, and lightning strike victim data. |
| average | 0.25313 |
| list Skip | 0.72381 |
| United States | 0.42455 |
| page options Skip | 0.942919 |
| mold | 0.252047 |
| thunder | 0.255266 |
| insects | 0.249259 |
| navigation Skip | 0.731772 |
| disaster | 0.244593 |
| lightning strike injuries | 0.791929 |
| times | 0.241753 |
|
| Illnesses | 0.252101 |
| cleanup | 0.258289 |
| earth | 0.241937 |
| carbon monoxide poisoning | 0.650553 |
| environmental concerns | 0.425608 |
| warning | 0.257512 |
| consequences | 0.256428 |
| risk | 0.239677 |
| animals | 0.237091 |
| family | 0.242511 |
|
CLICK HERE |
| 10220 |
Centers for Disease Control and Prevention |
Html |
en |
Key Facts About Protecting Yourself During a Volcanic Eruption'Volcanoes |
Information on volcanoes and public health. Provided by the Centers for Disease Control and Prevention (CDC). |
| hot gases | 0.759228 |
| volcanic eruptions | 0.761249 |
| dangers | 0.481992 |
| pyroclastic flows | 0.92895 |
| specific actions | 0.695771 |
| best advice | 0.682503 |
| warnings | 0.475816 |
| volcanoes | 0.595728 |
| flashfloods | 0.461705 |
| lava | 0.50078 |
|
| fast-moving flows | 0.908449 |
| ash | 0.487914 |
| debris | 0.599981 |
| attention | 0.46965 |
| local authorities | 0.706592 |
| toxic gases | 0.812348 |
| volcano | 0.481843 |
| hot water | 0.708552 |
| situation | 0.479041 |
|
CLICK HERE |
| 10348 |
Centers for Disease Control and Prevention |
Html |
en |
Science Clips - Monday, March 03, 2014 |
CDC - Stephen B. Thacker Library - Science Clips |
| endorsement | 0.367297 |
| current awareness | 0.377006 |
| findings | 0.265412 |
| asterisk | 0.246697 |
| focus | 0.234726 |
| prevention science | 0.420139 |
| science clips | 0.754527 |
| Healthcare Associated Infections | 0.567396 |
| Gail Bang | 0.394067 |
| Disease Control | 0.37745 |
| CDC Science Clips | 0.701412 |
| Kelli Sibert | 0.392155 |
| clinicians | 0.234187 |
| Librarian | 0.401926 |
| factual accuracy | 0.381422 |
| conclusions | 0.234623 |
| scientific articles | 0.415658 |
| Connick | 0.245111 |
| MLIS | 0.283896 |
| DHHS | 0.448816 |
| DISCLAIMER | 0.242378 |
| general review articles | 0.572798 |
| items | 0.278423 |
| United States | 0.393243 |
| Web Developer | 0.382038 |
|
| Victoria Burchfield | 0.384905 |
| authoritative sources | 0.399183 |
| MD MPH | 0.418033 |
| public health community | 0.618553 |
| Vital Signs issue | 0.569602 |
| scientific knowledge | 0.41901 |
| public health professionals | 0.578451 |
| scientific information | 0.398205 |
| omission | 0.244388 |
| public health | 0.911871 |
| views | 0.256994 |
| Jane Gidudu | 0.383691 |
| informational purposes | 0.366103 |
| public health literature | 0.548026 |
| B. Thacker CDC | 0.700319 |
| background information | 0.393452 |
| original authors | 0.379844 |
| opinion | 0.252 |
| non-CDC Websites | 0.376197 |
| John Iskander | 0.410669 |
| CDC Vital Signs | 0.744728 |
| news sources | 0.375104 |
| Editor | 0.260747 |
| public health research | 0.615406 |
|
CLICK HERE |
| 10523 |
Centers for Disease Control and Prevention |
Html |
en |
Conference Call September 24, 2013'Clinicians Outreach and Communication Activity (COCA) |
null |
| MPEG | 0.378858 |
| search | 0.263099 |
| PDF | 0.261307 |
| PPT | 0.446092 |
|
| DOC | 0.368812 |
| information | 0.262482 |
| different file formats | 0.938484 |
| page | 0.276773 |
|
CLICK HERE |
| 11254 |
Centers for Disease Control and Prevention |
Html |
es |
Parálisis cerebral: Evalúesus conocimientos |
¿Cuánto sabe de la parálisis cerebral? Responda este cuestionario para descubrirlo. |
| Archivo Apple Quicktime | 0.759196 |
| Archivo RealPlayer | 0.665668 |
| Archivo Zip Comprimido | 0.755697 |
| Archivo Microsoft PowerPoint | 0.781149 |
| Archivo Adobe PDF | 0.758043 |
|
| Archivo Microsoft Excel | 0.757217 |
| tanta rapidez | 0.671532 |
| Archivo Microsoft | 0.915283 |
| seguro médico | 0.659725 |
| wisconsin llamada gio | 0.810223 |
|
CLICK HERE |
| 13104 |
Centers for Disease Control and Prevention |
Html |
en |
Work-Related Asthma - 22 States, 2012 |
Jacek M. Mazurek, MD1, Gretchen E. White, MPH1,2 (Author affiliations at end of text). |
| work-exacerbated asthma | 0.439216 |
| data | 0.408307 |
| preventable occupational disease | 0.393577 |
| current asthma prevalence | 0.580771 |
| work-related asthma history | 0.483287 |
| WRA diagnosis | 0.44502 |
| WRA diagnosis§ | 0.477276 |
| adult asthma | 0.486681 |
| current asthma | 0.906004 |
| BRFSS | 0.468103 |
| government agencies | 0.38535 |
| health professionals | 0.38862 |
| Asthma Call-back Survey | 0.506832 |
| landline telephone samples | 0.409592 |
| adult data | 0.384919 |
| Jacek M. Mazurek | 0.392978 |
| BRFSS cellular telephone | 0.413614 |
| cellular telephone–only households | 0.45324 |
| statistical weighting | 0.386793 |
| adult-onset asthma cases | 0.463567 |
| Behavioral Risk Factor | 0.385003 |
| proportion | 0.416089 |
| ever-employed adults | 0.539266 |
| WRA | 0.706362 |
| Ever-employed ACBS participants | 0.44813 |
|
| adverse health outcomes | 0.399589 |
| preventive health practices | 0.392682 |
| states | 0.48361 |
| Occupational Safety | 0.407506 |
| health risk factors | 0.390547 |
| ACBS WRA section | 0.564738 |
| WRA question | 0.464095 |
| weighting methodology | 0.390354 |
| state asthma programs | 0.469449 |
| National Institute | 0.412582 |
| public health | 0.409237 |
| work-related asthma diagnosis | 0.483158 |
| random-digit–dialed telephone survey | 0.388941 |
| BRFSS completion date | 0.392903 |
| BRFSS state coordinators | 0.384654 |
| ACBS median response | 0.431057 |
| CDC-funded ACBS | 0.413222 |
| health | 0.432784 |
| occupational exposures | 0.405398 |
| ACBS question | 0.420994 |
| cellular telephone samples | 0.669985 |
| Occupational Health Branch | 0.387152 |
| WRA cases | 0.450912 |
| asthma symptoms | 0.432503 |
|
CLICK HERE |
| 13586 |
Centers for Disease Control and Prevention |
Html |
en |
Intervals Between PCV13 and PPSV23 Vaccines: Recommendationsof the Advisory Committee on Immunization Practices ACIP |
Please note: An erratum has been published for this article. To view the erratum, please click here. |
| pneumococcal vaccines | 0.644878 |
| added significant complexity | 0.457824 |
| http://www.cdc.gov/vaccines/acip/recs/grade/pneumo-immuno-child.html), immunocompromised adults | 0.511851 |
| immune responses | 0.549255 |
| polysaccharide vaccine | 0.608912 |
| pneumococcal vaccine | 0.744412 |
| recommended dosing intervals | 0.563017 |
| advisory committee | 0.621524 |
| antibody levels | 0.470196 |
| cochlear implants | 0.480156 |
| pneumococcal conjugate vaccine | 0.575524 |
| Vaccines Working Group | 0.53576 |
| pneumococcal vaccine naУÐ?ve | 0.527088 |
| available evidence | 0.467244 |
| PCV13–PPSV23 sequence | 0.791143 |
| improved immune response | 0.464963 |
| Alaska Native adults | 0.498781 |
| intervals | 0.678154 |
| dose | 0.597935 |
| 6-month interval | 0.481323 |
| medical conditions | 0.477893 |
| interval | 0.797181 |
| Cynthia G. Whitney | 0.482518 |
| pneumococcal polysaccharide vaccine | 0.581175 |
| Tamara Pilishvili | 0.486061 |
|
| immunogenicity studies | 0.472477 |
| risk window | 0.466268 |
| vaccines | 0.902831 |
| 1-year interval | 0.662198 |
| United States | 0.585961 |
| age group | 0.540456 |
| 2-month interval | 0.480328 |
| immunocompromising conditions | 0.475282 |
| invasive pneumococcal disease | 0.604941 |
| Immunization Practices | 0.555372 |
| immunocompetent adults | 0.923348 |
| single PPSV23 dose | 0.556485 |
| immune response | 0.561676 |
| ACIP | 0.88574 |
| studies | 0.478753 |
| longer intervals | 0.493998 |
| pneumococcal vaccine series | 0.524383 |
| 8-week interval | 0.470262 |
| conjugate vaccine | 0.602952 |
| serotypes | 0.458122 |
| optimal interval | 0.484117 |
| best available evidence | 0.46327 |
| ACIP recommendations | 0.603598 |
| Vaccine Adverse Events | 0.492002 |
|
CLICK HERE |
| 13948 |
Centers for Disease Control and Prevention |
Html |
en |
Syringe Service Programs for Persons Who Inject Drugs inUrban, Suburban, and Rural Areas - United States, 2013 |
The Morbidity and Mortality Weekly Report (MMWR) Series is prepared by the Centers for Disease Control and Prevention (CDC). Often called 'the Voice of CDC,' the MMWR series is the agency's primary vehicle for scientific publication of timely, reliable, authoritative, accurate, objective, and useful public health information and recommendations. MMWR readership predominately consists of physicians, nurses, public health practitioners, epidemiologists and other scientists, researchers, educators, and laboratorians. |
| risk reduction programs | 0.373475 |
| data | 0.345762 |
| rural ssps | 0.722469 |
| urban SSPs | 0.641815 |
| HIV prevention | 0.376844 |
| risk reduction efforts | 0.443335 |
| rural programs | 0.391322 |
| U.S. SSPs | 0.353057 |
| urban primary locations | 0.36347 |
| prevention services | 0.342676 |
| multiple areas | 0.354059 |
| American Syringe Exchange | 0.445117 |
| rural areas | 0.373763 |
| suburban areas | 0.544242 |
| SSPs | 0.967079 |
| primary suburban locations | 0.442995 |
| effective prevention programs | 0.380477 |
| major urban areas | 0.403978 |
| Viral Hepatitis | 0.352 |
| urban programs | 0.44358 |
| Sinai Beth Israel | 0.444205 |
| rural setting | 0.354967 |
| program directors | 0.434243 |
| syringes | 0.4755 |
| acute HCV infection | 0.400357 |
|
| programs | 0.501328 |
| recent HIV outbreak | 0.375337 |
| HCV infection | 0.79431 |
| United States | 0.689853 |
| PWID | 0.434957 |
| harm reduction services | 0.354005 |
| HCV testing | 0.44342 |
| Substantially fewer SSPs | 0.430563 |
| syringe service programs | 0.389734 |
| Indiana HIV outbreak | 0.355492 |
| drug injection | 0.395773 |
| New York | 0.434234 |
| primary rural locations | 0.384079 |
| HIV incidence | 0.370507 |
| sterile needles | 0.401616 |
| Syringe Exchange Network | 0.447741 |
| services | 0.41194 |
| suburban ssps | 0.615759 |
| HIV | 0.487338 |
| suburban programs | 0.42472 |
| HCV-contaminated syringes | 0.350089 |
| sterile syringes | 0.377322 |
| primary urban locations | 0.374895 |
| previous SSP surveys | 0.342688 |
|
CLICK HERE |